General

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9-12 March 2020

Mar 13, 2020 EMA Healthcare Agency

PRAC starts review of certain ifosfamide cancer medicines At its monthly meeting, EMA’s safety committee (PRAC) has started a review…

EMA HEALTHCARE AGENCY